NGS-Based RNA-Seq Market to surpass US$ 7,984.90 Mn in 2027 : Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., BGI, Oxford Nanopore Technologies
The NGS based RNA seq is done without a reference sequence for the strand-specific libraries that are being profiled for the rare and novel therapeutics. It is highly revolutionized study of the transcriptome which is highly sensitive and accurate for the measurement of the expression all over the transcriptome. The NGs based RNA seq provides researchers with visibility for previously undetected changes occurring in disease states, in response to therapeutics caused by different environmental conditions. In addition, this technique enables researchers to detect the known and unknown features in single assay. The report would be of an interest to various stakeholders operating in the NGS based RNA seq market. These stakeholders include manufacturing companies, dealer companies, supplier companies, wholesalers, hospitals, research centers and others.
Request Sample Copy of this Report@: http://bit.ly/2T7zSDV
NGS-Based RNA-Seq Market includes the top key players such:Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., BGI, Oxford Nanopore Technologies, Perkinelmer, Inc. and Eurofins Scientific.
The objective of the study is to describe, define, and forecast the NGS based RNA seq market by product & services, technology, application, end user and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.
The global NGS based RNA seq market is expected to reach US$ 7,984.90 Mn in 2027 from 1,414.59 in 2018. The market is estimated to grow with a CAGR of 19.3% from 2018-2027.
NGS based RNA seq market is segmented by product & services, technology, application and end user. Global NGS based RNA seq market, based on product & services was segmented into sample preparation, sequencing services, sequencing platform & consumables and data analysis, storage & management. Global NGS based RNA seq market, based on technology was segmented into sequencing by synthesis, nanopore sequencing, ion semiconductor sequencing and single molecule real time sequencing. Global NGS based RNA seq market, based on application was classified as diagnostics, drug discovery, precision medicine and others. And on the basis of the end user the global NGS based RNA seq market was segmented as biotechnology & pharmaceutical companies, hospitals & clinics, research centers and academic & government institutes and others.
The NGS based RNA seq market report analyzes factors affecting NGS based RNA seq market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, , opportunities, and future trend. The report provides the analysis for the every segment in detail across all the regions such as North America, Europe, Asia Pacific, Middle East & Africa and South and Central America.
The market players offers products such as reagents and kits, instruments and consumables required for the sequencing. Among the companies profiled in the report Illumina Inc. and Thermo Fisher Scientific Inc. are the top two major players operating in the market.
Buy This Informative Research Report http://bit.ly/2T2qv8i
Objective of the Study:
1. Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global NGS-Based RNA-Seq Market
2. Highlights key business priorities in order to assist companies to realign their business strategies
3. The key findings and recommendations highlight crucial progressive industry trends in the NGS-Based RNA-Seq Market, thereby allowing players across the value chain to develop effective long term strategies
4. Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
5. Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
6. Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
7. Examine the political, economic, social and technology impact of the five regions namely: North America, Europe, Asia Pacific, Middle East & Africa and South America.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release NGS-Based RNA-Seq Market to surpass US$ 7,984.90 Mn in 2027 : Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., BGI, Oxford Nanopore Technologies here
News-ID: 1520675 • Views: 90
More Releases from The Insight Partners
Trade Management Software Market Will Generate New Growth Opportunities In 2027
The global trade management software market valued at US$ 712.3 Mn in 2018 and is expected to grow at a CAGR of 9.6% during the forecast period 2019 - 2027, to account to US$ 1,607.2 Mn in 2027. A Professional Survey done by The Insight partners has formulated a report titled "Trade Management Software Market", which instills a crisp idea of the influential aspects affecting the growth of the market. It
Integrated Platform Management System Market Future Forecast Assessed On The Bas …
The integrated platform management systems (IPMS) are the sophisticated control system solutions for naval vehicles such as aircraft carriers, frigates, and submarines. They control and monitor virtually every mechanical system on a ship. These systems incorporate HVAC, electrical, propulsion, auxiliary, and damage control systems in one integrated solution. The incorporation of the system also removes standalone third party control equipment reducing weight, space, and cabling and thereby delivering increased supportability
Image Analysis Software Market to 2020-2027 by Key Companies - MIPAR, PAX-it, Ol …
Worldwide Image Analysis Software Market Analysis to 2027 is a specialized and in-depth study of the Image Analysis Software industry with a focus on the global market trend. The report aims to provide an overview of global Image Analysis Software Market with detailed market segmentation by product/application and geography. The global Image Analysis Software Market is expected to witness high growth during the forecast period. The report provides key statistics
Middle Office Outsourcing Market to Witness Huge Growth by 2027 - Adepa Global S …
To thrive in this rapidly transforming marketplace, today's businesses call for innovative and superlative solutions. Being an outstanding resource of market info, the Middle Office Outsourcing Market report provides recent as well as upcoming technical and financial details of the industry to 2027. Clients accomplish unparalleled insights and acquaintance of the best market opportunities into their respective markets from this market report. Market segmentation is also covered in detail by
More Releases for RNA
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
Automated DNA/RNA Isolation System Market Overview Till 2018-2023
Future Market Reports on Global Automated DNA/RNA Isolation System 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Automated DNA/RNA Isolation System Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Automated DNA/RNA Isolation System market players and the future prospects from various angles
RNA Sequencing: Technologies and Analyses of Global Market Trends
"The Latest Research Report RNA Sequencing: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate (CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8
Topics Presented this February 2018 at RNA Therapeutics
SMi’s RNA Therapeutics will be bringing a global presence from MHRA, The RNA Institute, MiNA Therapeutics, AstraZeneca R&D, GSK, Sanofi, CureVac and more. With an agenda full of exciting and new approaches, examine the latest developments in delivery systems for RNA Therapeutics, including Exosomes, Nanocomplexes and Platform Delivery Approaches and patenting RNA Therapeutics. www.therapeutics-rna.com/opr Spotlight: Want to learn about exploiting exosomes for therapeutic use in patients with cystic fibrosis? Have questions answered during
RNA Analysis Market worth 3.62 billion USD by 2021
RNA Analysis Market size was around USD 1.89 billion in 2016. It is expected to grow at a CAGR of 13.9% to reach USD 3.62 billion by 2021. The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led